Palo Alto, CA
,
USA
·
North America
Samsara BioCapital is a Palo Alto-based life sciences venture capital firm focused on early-stage biotechnology companies developing innovative medicines for serious diseases. The firm backs Seed through Series B companies, typically deploying $3M–$15M. Portfolio companies include Aavantibio, Disc Medicine, Larimar Therapeutics, and Prime Medicine.
Know when they open it, which slides they read, and when to follow up.
Pitchwise turns every shared deck into a live intelligence feed.
